206 related articles for article (PubMed ID: 33963961)
1. Medulloblastoma recurrence and metastatic spread are independent of colony-stimulating factor 1 receptor signaling and macrophage survival.
Crotty EE; Smith SMC; Brasel K; Pakiam F; Girard EJ; Connor YD; Zindy F; Mhyre AJ; Roussel MF; Olson JM
J Neurooncol; 2021 Jun; 153(2):225-237. PubMed ID: 33963961
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated macrophages in SHH subgroup of medulloblastomas.
Margol AS; Robison NJ; Gnanachandran J; Hung LT; Kennedy RJ; Vali M; Dhall G; Finlay JL; Erdreich-Epstein A; Krieger MD; Drissi R; Fouladi M; Gilles FH; Judkins AR; Sposto R; Asgharzadeh S
Clin Cancer Res; 2015 Mar; 21(6):1457-65. PubMed ID: 25344580
[TBL] [Abstract][Full Text] [Related]
3. Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma.
Maximov V; Chen Z; Wei Y; Robinson MH; Herting CJ; Shanmugam NS; Rudneva VA; Goldsmith KC; MacDonald TJ; Northcott PA; Hambardzumyan D; Kenney AM
Nat Commun; 2019 Jun; 10(1):2410. PubMed ID: 31160587
[TBL] [Abstract][Full Text] [Related]
4. Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain Metastasis.
Wu AML; Gossa S; Samala R; Chung MA; Gril B; Yang HH; Thorsheim HR; Tran AD; Wei D; Taner E; Isanogle K; Yang Y; Dolan EL; Robinson C; Difilippantonio S; Lee MP; Khan I; Smith QR; McGavern DB; Wakefield LM; Steeg PS
Clin Cancer Res; 2021 Aug; 27(15):4422-4434. PubMed ID: 34083229
[TBL] [Abstract][Full Text] [Related]
5. Macrophage colony-stimulating factor and its role in the tumor microenvironment: novel therapeutic avenues and mechanistic insights.
Yi L; Gai Y; Chen Z; Tian K; Liu P; Liang H; Xu X; Peng Q; Luo X
Front Oncol; 2024; 14():1358750. PubMed ID: 38646440
[TBL] [Abstract][Full Text] [Related]
6. Chlorin e6 and BLZ945 Based Self-Assembly for Photodynamic Immunotherapy Through Immunogenic Tumor Induction and Tumor-Associated Macrophage Depletion.
Huang CY; Zhao LP; Rao XN; Zheng RR; Liu ZS; Cai H; Zhang W; Chen AL; Xu L; Li S
Adv Healthc Mater; 2024 Apr; ():e2304576. PubMed ID: 38689517
[TBL] [Abstract][Full Text] [Related]
7. Targeted systemic dendrimer delivery of CSF-1R inhibitor to tumor-associated macrophages improves outcomes in orthotopic glioblastoma.
Liaw K; Reddy R; Sharma A; Li J; Chang M; Sharma R; Salazar S; Kannan S; Kannan RM
Bioeng Transl Med; 2021 May; 6(2):e10205. PubMed ID: 34027092
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma.
Khang M; Lee JH; Lee T; Suh HW; Lee S; Cavaliere A; Rushing A; Geraldo LH; Belitzky E; Rossano S; de Feyter HM; Shin K; Huttner A; Roussel MF; Thomas JL; Carson RE; Marquez-Nostra B; Bindra RS; Saltzman WM
Sci Transl Med; 2023 Nov; 15(720):eadi1617. PubMed ID: 37910601
[TBL] [Abstract][Full Text] [Related]
9. ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination.
Jones JK; Zhang H; Lyne AM; Cavalli FMG; Hassen WE; Stevenson K; Kornahrens R; Yang Y; Li S; Dell S; Reitman ZJ; Herndon JE; Hoj J; Pendergast AM; Thompson EM
Neurooncol Adv; 2023; 5(1):vdad095. PubMed ID: 37781087
[TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal dissemination: a sinister pattern of medulloblastoma growth.
Fults DW; Taylor MD; Garzia L
J Neurosurg Pediatr; 2019 Feb; 23(5):613-621. PubMed ID: 30771762
[TBL] [Abstract][Full Text] [Related]
11. Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.
Martirosian V; Deshpande K; Zhou H; Shen K; Smith K; Northcott P; Lin M; Stepanosyan V; Das D; Remsik J; Isakov D; Boire A; De Feyter H; Hurth K; Li S; Wiemels J; Nakamura B; Shao L; Danilov C; Chen T; Neman J
Cell Rep; 2021 Jul; 36(4):109475. PubMed ID: 34320362
[No Abstract] [Full Text] [Related]
12. Cryptic developmental events determine medulloblastoma radiosensitivity and cellular heterogeneity without altering transcriptomic profile.
Malawsky DS; Weir SJ; Ocasio JK; Babcock B; Dismuke T; Cleveland AH; Donson AM; Vibhakar R; Wilhelmsen K; Gershon TR
Commun Biol; 2021 May; 4(1):616. PubMed ID: 34021242
[TBL] [Abstract][Full Text] [Related]
13. Identification of pseudolaric acid B as a novel Hedgehog pathway inhibitor in medulloblastoma.
Wei SF; He DH; Zhang SB; Lu Y; Ye X; Fan XZ; Wang H; Wang Q; Liu YQ
Biochem Pharmacol; 2021 Aug; 190():114593. PubMed ID: 33964282
[TBL] [Abstract][Full Text] [Related]
14. Depletion of kinesin motor KIF20A to target cell fate control suppresses medulloblastoma tumour growth.
Qiu R; Wu J; Gudenas B; Northcott PA; Wechsler-Reya RJ; Lu Q
Commun Biol; 2021 May; 4(1):552. PubMed ID: 33976373
[TBL] [Abstract][Full Text] [Related]
15. The Hippo-TAZ axis mediates vascular endothelial growth factor C in glioblastoma-derived exosomes to promote angiogenesis.
Wang Z; Yuan Y; Ji X; Xiao X; Li Z; Yi X; Zhu Y; Guo T; Wang Y; Chen L; Liu Y
Cancer Lett; 2021 Aug; 513():1-13. PubMed ID: 34010715
[TBL] [Abstract][Full Text] [Related]
16. Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma.
Buck J; Dyer PJC; Hii H; Carline B; Kuchibhotla M; Byrne J; Howlett M; Whitehouse J; Ebert MA; McDonald KL; Gottardo NG; Endersby R
Front Mol Biosci; 2021; 8():633344. PubMed ID: 33996894
[TBL] [Abstract][Full Text] [Related]
17. Changes in Peripheral Blood Regulatory T Cells and IL-6 and IL-10 Levels Predict Response of Pediatric Medulloblastoma and Germ Cell Tumors With Residual or Disseminated Disease to Craniospinal Irradiation.
Song L; Wang S; Fang T; Qiu X; Wang X; Zhou X; Morse MA; Hobeika A; Wu W; Yang H; Ren J; Lyerly HK
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):479-490. PubMed ID: 33974888
[TBL] [Abstract][Full Text] [Related]
18. WNT/β-catenin-suppressed FTO expression increases m
Yang X; Shao F; Guo D; Wang W; Wang J; Zhu R; Gao Y; He J; Lu Z
Cell Death Dis; 2021 May; 12(5):462. PubMed ID: 33966037
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative and antimetastatic characterization of an exo-heterocyclic androstane derivative against human breast cancer cell lines.
Kulmány ÁE; Frank É; Kovács D; Kirisits K; Krupitza G; Neuperger P; Alföldi R; Puskás LG; Szebeni GJ; Zupkó I
Biomed Pharmacother; 2021 Aug; 140():111728. PubMed ID: 34020244
[TBL] [Abstract][Full Text] [Related]
20. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
